A sensitive and rapid method for quantification of lacosamide and desmethyl lacosamide by LC–MS/MS
Abstract
Background: Monitoring lacosamide (LCM) helps optimize therapeutic dosing in some clinical settings. We developed a novel LC–MS/MS method for measuring serum LCM and O-desmethyl lacosamide (ODL). Results/discussion: The sample preparation was protein precipitation with methanol. The total CV was less than 4.7%. Calibration range was 0.95–30.29 µg/ml and 0.95–30.41 µg/ml while the expanded linear range was 0.41–47.49 µg/ml and 0.34–48.17 µg/ml for LCM and ODL, respectively with analytical accuracy of 87.2–106.0%. 45 random serum samples collected from 23 individuals on either 200 mg/day or 400 mg/day of LCM therapy showed concentrations of 2.2–19.8 µg/ml for LCM and up to 2.5 µg/ml for ODL. Conclusion: A simple and sensitive LC–MS/MS assay was validated for quantification of LCM and ODL in human serum.
Papers of special note have been highlighted as: • of interest
References
- 1 Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 50(3), 443–453 (2009).
- 2 . A high-performance liquid chromatography assay to monitor the new antiepileptic drug lacosamide in patients with epilepsy. Ther. Drug Monit. 32(4), 448–452 (2010).• Importance of therapeutic drug monitoring.
- 3 Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials. CNS Drugs 24(12), 1041–1054 (2010).
- 4 . Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: saliva as a surrogate of pharmacokinetics in the central compartment. Epilepsia 54(1), 81–88 (2013).• Identifies the major human metabolite of lacosamide.
- 5 Liquid chromatography–tandem mass spectrometry for quantification of lacosamide, an antiepileptic drug, in rat plasma and its application to pharmacokinetic study. Biomed. Chromatogr. 26(3), 371–376 (2012).• An LC–MS/MS method for the measurement of lacosamide.
- 6 . Therapeutic drug monitoring of the newer anti-epilepsy medications. Pharmaceuticals (Basel) 3(6), 1909–1935 (2010).
- 7 . A review on new antiepileptic drug–Lacosamide and its analytical methods. International journal of chemical and pharmaceutical sciences 2, 181–186 (2013).
- 8 A simple HPLC-UV method for the determination of lacosamide in human plasma. Bioanalysis 3(22), 2515–2522 (2011).
- 9 High-performance liquid chromatographic analysis of lacosamide in canine serum using ultraviolet detection: application to pre-clinical pharmacokinetics in dogs. Biomed. Chromatogr. 26(5), 606–609 (2012).
- 10 . Fully validated method for rapid and simultaneous measurement of six antiepileptic drugs in serum and plasma using ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Talanta 110, 71–80 (2013).• An UPLC–MS/MS method for the measurement of lacosamide with two transitions monitored.
- 11 . Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis. Clin. Chem. 54(9), 1519–1527 (2008).
- 12 . Ion suppression in mass spectrometry. Clin. Chem. 49(7), 1041–1044 (2003).
- 13 . Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin. Chem. 56(8), 1234–1244 (2010).
